Skip to main content

BIIB

BIOGEN INC.
Sector
Health Care
Industry
Biotechnology
Last price
$196.74
As of

Active signals for BIIB

Top institutional holders of BIIB (13F)

FundMarket value% portfolioQoQ
Point72 Asset Management, L.P.$176.3M0.20%+0.1%
Point72 Asset Management, L.P.$140.1M0.23%,
RENAISSANCE TECHNOLOGIES LLC$135.1M0.18%,
RENAISSANCE TECHNOLOGIES LLC$70.3M0.11%-58.6%
TWO SIGMA INVESTMENTS, LP$44.3M0.06%+22.7%
RENAISSANCE TECHNOLOGIES LLC$37.3M0.06%-49.0%
MILLENNIUM MANAGEMENT LLC$36.6M0.02%,
TWO SIGMA INVESTMENTS, LP$28.7M0.04%,
CITADEL ADVISORS LLC$28.5M0.00%+2.5%
CITADEL ADVISORS LLC$22.1M0.00%,
MILLENNIUM MANAGEMENT LLC$19M0.01%+2.8%
MILLENNIUM MANAGEMENT LLC$17.8M0.01%-61.3%
Bridgewater Associates, LP$5.6M0.02%,
TWO SIGMA INVESTMENTS, LP$1.7M0.00%-96.2%
D. E. Shaw & Co., Inc.$1.2M0.00%+0.0%
D. E. Shaw & Co., Inc.$1.1M0.00%-7.2%
D. E. Shaw & Co., Inc.$967K0.00%,
Point72 Asset Management, L.P.$862K0.00%-99.5%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, BIIB

Related tickers in Health Care

See more BIIB signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track BIIB in your watchlist and get notified the moment a new signal fires.

Track BIIB on Kresmion →